CEMIPLIMAB (se MIP li mab) treats skin cancer and lung cancer. It works by helping your immune system slow or stop the spread of cancer cells. It is a monoclonal antibody. This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions. What should I tell my care team before I take this medication?

Dec 5, 2024 · Libtayo (cemiplimab-rwlc) is used to treat metastatic cutaneous squamous cell carcinoma, basal cell carcinoma, and non-small cell lung cancer. Includes Libtayo side effects, interactions and indications.

Oct 3, 2022 · Is Libtayo a chemotherapy drug? No, Libtayo isn’t a chemotherapy drug. Chemotherapy drugs are traditional cancer treatments. They work by killing cells that are multiplying rapidly in...

LIBTAYO is indicated for the treatment of patients with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced CSCC (laCSCC) who are not candidates for curative surgery or curative radiation.

LIBTAYO is a prescription medication used to treat people with a type of skin cancer called cutaneous squamous cell carcinoma (CSCC) that has spread or cannot be cured by surgery or radiation. It is not known if LIBTAYO is safe and effective in children.

Nov 19, 2021 · How does cemiplimab work? Cemiplimab is designed to block the signals that tumor cells use to suppress the immune system allowing the immune system to attack the lung cancer cells. Cemiplimab is given to decrease symptoms from non-small-cell lung cancer (NSCLC) and to slow its spread to other parts of the body.

LIBTAYO in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with non-small cell lung cancer (NSCLC) with no EGFR, ALK or ROS1 aberrations and is locally advanced where patients are not candidates for surgical resection or definitive chemoradiation OR metastatic.

On November 8, 2022, the Food and Drug Administration approved cemiplimab-rwlc (Libtayo, Regeneron Pharmaceuticals, Inc.) in combination with platinum-based chemotherapy for adult patients with...

Oct 28, 2024 · Libtayo is a specific kind of medicine called immunotherapy. Immunotherapies work by helping your body’s own immune system work to fight against cancer. Libtayo works by attaching itself to a...

LIBTAYO is a prescription medication used to treat people with a type of skin cancer called cutaneous squamous cell carcinoma (CSCC) that has spread or cannot be cured by surgery or radiation. It is not known if LIBTAYO is safe and effective in children.